Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

NCT05177731 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

188

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult
Chemotherapy Effect

Interventions

DRUG: Venetoclax
DRUG: Decitabine for Injection
DRUG: Cytarabine
DRUG: Idarubicin
DRUG: Gilteritinib

Sponsor

Chen Suning